We are live on ! Find out more
EW icon

Edwards Lifesciences

658 hedge funds and large institutions have $15.9B invested in Edwards Lifesciences in 2016 Q1 according to their latest regulatory filings, with 102 funds opening new positions, 220 increasing their positions, 243 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed

162% more first-time investments, than exits

New positions opened: 102 | Existing positions closed: 39

52% more call options, than puts

Call options by funds: $175M | Put options by funds: $115M

9% more funds holding

Funds holding: 604658 (+54)

6% more ownership

Funds ownership: 254.73%260.73% (+6%)

0% more funds holding in top 10

Funds holding in top 10: 1616 (0)

9% less repeat investments, than reductions

Existing positions increased: 220 | Existing positions reduced: 243

6% less capital invested

Capital invested by funds: $16.9B → $15.9B (-$1.06B)

Holders
658
Holders Change
+54
Holders Change %
+8.94%
% of All Funds
17.53%
Holding in Top 10
16
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.43%
New
102
Increased
220
Reduced
243
Closed
39
Calls
$175M
Puts
$115M
Net Calls
+$59.8M
Net Calls Change
+$20.1M
Name Holding Trade Value Shares
Change
Change in
Stake
DAS
401
Dynamic Advisor Solutions
Arizona
$876K -$47.3K -1,716 -5%
PCMI
402
Paradigm Capital Management Inc
New York
$864K
KRSITF
403
Kentucky Retirement Systems Insurance Trust Fund
Kentucky
$857K +$135K +4,896 +20%
DCM
404
Driehaus Capital Management
Illinois
$839K +$788K +28,542 New
CG
405
Clinton Group
New York
$817K -$2.83M -102,645 -79%
SEC
406
Seven Eight Capital
New York
$812K +$397K +14,400 +109%
LCM
407
Laurion Capital Management
New York
$812K +$762K +27,600 New
GCP
408
GSA Capital Partners
United Kingdom
$804K -$820K -29,721 -52%
MP
409
Manifold Partners
California
$800K +$750K +27,195 New
ICM
410
IMS Capital Management
Oregon
$776K
RJFSA
411
Raymond James Financial Services Advisors
Florida
$772K +$724K +26,247 New
AB
412
Amalgamated Bank
New York
$754K +$168K +6,093 +31%
AL
413
Airain Ltd
Guernsey
$750K +$704K +25,509 New
ECM
414
Everence Capital Management
Indiana
$726K
CCG
415
Cypress Capital Group
Florida
$725K +$95.9K +3,474 +16%
NMIMC
416
Northwestern Mutual Investment Management Company
Wisconsin
$722K -$2.1M -76,203 -76%
EVM
417
Evelyn V. Moreno
$706K
SFFS
418
Stonehage Fleming Financial Services
Jersey
$702K +$659K +23,868 New
GLA
419
Great Lakes Advisors
Illinois
$690K +$141K +5,097 +28%
IH
420
IFC Holdings
Florida
$684K +$631K +22,860 New
CB
421
Commerce Bank
Missouri
$680K -$8.53K -309 -1%
Mackenzie Financial
422
Mackenzie Financial
Ontario, Canada
$679K -$1.81M -65,700 -74%
TMAM
423
Tokio Marine Asset Management
Japan
$668K +$77.1K +2,796 +14%
MLL
424
Moody Lynn & Lieberson
Massachusetts
$659K +$618K +22,410 New
AP
425
AHL Partners
United Kingdom
$652K -$362K -13,125 -37%

EW Hedge Fund Activity: Q1 2016 in Review

658 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Edwards Lifesciences (EW) for Q1 2016, worth a combined $15.9B — down 6.2% from $16.9B a quarter earlier.

Buyers outnumbered sellers: 102 funds opened new EW positions and 39 closed out — a net gain of 63 holders — while 220 added to existing stakes and 243 trimmed.

The largest buyer was Royal London Asset Management, adding an estimated $378M. The largest seller was Americafirst Capital Management, exiting entirely with an estimated $2.46B sold.

  • 658 institutional investors held Edwards Lifesciences (EW) as of Q1 2016, up from 604 in Q4 2015.
  • Funds reported $15.9B of Edwards Lifesciences stock for Q1 2016, down 6.2% quarter-over-quarter.
  • 102 funds opened new Edwards Lifesciences positions in Q1 2016 and 39 closed out, a net change of +63 holders.
  • The largest Edwards Lifesciences buyer in Q1 2016 was Royal London Asset Management, an estimated $378M added.
  • The largest Edwards Lifesciences seller in Q1 2016 was Americafirst Capital Management, an estimated $2.46B sold.

Based on aggregated 13F filings for Q1 2016.